Previously, high expression of COL6A1 has been reported to predict poor prognosis in pancreatic cancer and cervical cancer [13, 28], and similar effects of COL6A1/2/3 are also seen in triple-negative breast cancer (TNBC) [29]. Here, COL6A1 is linked to triple-negative breast carcinoma.